259 related articles for article (PubMed ID: 28335003)
1. Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease.
Gallone G; Haerty W; Disanto G; Ramagopalan SV; Ponting CP; Berlanga-Taylor AJ
Hum Mol Genet; 2017 Jun; 26(11):2164-2176. PubMed ID: 28335003
[TBL] [Abstract][Full Text] [Related]
2. Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans.
Adams C; Manouchehrinia A; Quach HL; Quach DL; Olsson T; Kockum I; Schaefer C; Ponting CP; Alfredsson L; Barcellos LF
Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2302259121. PubMed ID: 38346204
[TBL] [Abstract][Full Text] [Related]
3. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
4. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
5. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.
Ramagopalan SV; Heger A; Berlanga AJ; Maugeri NJ; Lincoln MR; Burrell A; Handunnetthi L; Handel AE; Disanto G; Orton SM; Watson CT; Morahan JM; Giovannoni G; Ponting CP; Ebers GC; Knight JC
Genome Res; 2010 Oct; 20(10):1352-60. PubMed ID: 20736230
[TBL] [Abstract][Full Text] [Related]
6. Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.
Singh PK; van den Berg PR; Long MD; Vreugdenhil A; Grieshober L; Ochs-Balcom HM; Wang J; Delcambre S; Heikkinen S; Carlberg C; Campbell MJ; Sucheston-Campbell LE
BMC Genomics; 2017 Feb; 18(1):132. PubMed ID: 28166722
[TBL] [Abstract][Full Text] [Related]
7. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
9. Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor.
Jin CH; Pike JW
Mol Endocrinol; 1996 Feb; 10(2):196-205. PubMed ID: 8825559
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone.
Meyer MB; Goetsch PD; Pike JW
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):136-41. PubMed ID: 20171278
[TBL] [Abstract][Full Text] [Related]
11. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
Lemon BD; Freedman LP
Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
Kephart DD; Walfish PG; DeLuca H; Butt TR
Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
[TBL] [Abstract][Full Text] [Related]
13. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
Berghöfer-Hochheimer Y; Zurek C; Wölfl S; Hemmerich P; Munder T
J Cell Biochem; 1998 Apr; 69(1):1-12. PubMed ID: 9513041
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor and RXR in the post-genomic era.
Long MD; Sucheston-Campbell LE; Campbell MJ
J Cell Physiol; 2015 Apr; 230(4):758-66. PubMed ID: 25335912
[TBL] [Abstract][Full Text] [Related]
15. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
[TBL] [Abstract][Full Text] [Related]
16. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
[TBL] [Abstract][Full Text] [Related]
17. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
18. Heterodimer requirement for gene regulation by Vitamin D in variant OK cells.
Koszewski NJ; Rowan A
Steroids; 2003 Apr; 68(4):307-14. PubMed ID: 12787891
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
Prüfer K; Barsony J
Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
[TBL] [Abstract][Full Text] [Related]
20. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
